Cognis Prevastein "Bone Health" Claim Cleared By FDA
This article was originally published in The Tan Sheet
Executive Summary
Cognis Nutrition & Health is preparing to introduce its Prevastein soy isoflavone ingredient for post-menopausal "bone health" following resolution with FDA of potential structure/function claim language.